보고서 요약(국문)

개요
전 세계 튜브리스 인슐린 펌프 시장은 2022년 YY백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
튜브리스 인슐린 펌프는 기본적으로 몸에 직접 부착하는 패치 형태로, 무선 휴대용 기기로 제어되어 눈에 띄지 않게 인슐린을 투여할 수 있습니다. 이 펌프는 화면이 없으며 블루투스를 통해 터치스크린 휴대용 기기로 무선 제어됩니다. 방수 기능이 있는 폐쇄 루프 인슐린 펌프에 내장된 알고리즘은 인슐린 방출 과정을 위해 연속 혈당 측정기와 직접 통신합니다.
또한, 튜브리스 인슐린 펌프는 1형 및 2형 당뇨병 환자들이 혈당 수치를 편리하게 관리하는 데 도움을 줄 수 있습니다. 이 작은 기기는 특정 시간에 인슐린을 투여합니다. 튜브리스 인슐린 펌프는 인슐린 펜 주사나 다른 인슐린 기기보다 더 유연한 선택지입니다. 영구적으로 사용할 필요가 없으며 언제든지 다른 인슐린 관리 방법으로 전환할 수 있습니다. 튜브리스 인슐린 펌프는 환자에게 편리하며, 무선 기기를 사용하여 인슐린을 투여할 수 있습니다.
시장 동향: 성장 요인
튜브리스 인슐린 펌프 기술의 발전
튜브리스 펌프 기술의 발전은 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 이러한 펌프 기술의 발전은 튜브리스 인슐린 펌프의 보급 확대를 촉진할 것입니다. 튜브리스 인슐린 펌프 기술의 발전으로 더욱 작고 편안하며 사용하기 쉬운 기기가 개발될 수 있습니다. 사용자 경험 개선은 환자 만족도 향상으로 이어질 수 있습니다.
예를 들어, 로슈는 2023년 8월 Accu-Chek Solo 인슐린 패치 펌프와 무선 터치스크린 휴대용 기기를 출시했으며, 2세 이상 당뇨병 환자 사용에 대해 FDA 승인을 받았습니다. 이 시스템은 튜브리스 인슐린 펌프와 블루투스 기능이 있는 무선 휴대용 컨트롤러로 구성되어 있으며, 혈당 모니터링 및 볼러스 투여량 안내 기능을 제공합니다. 이 인슐린 펌프 시스템은 튜브가 없고 크기가 작고 가볍습니다. 또한, 기기를 분리할 수 있어 당뇨병 환자가 필요에 따라 주입 부위를 변경할 수 있습니다.

더욱이, 튜브리스 인슐린 펌프가 CGM 시스템과 원활하게 통합되도록 설계되어 혈당 모니터링 및 자동 인슐린 조절 기능을 향상시킨다면 당뇨병 관리가 크게 개선될 수 있습니다. 이는 환자의 치료 결과 개선으로 이어지고, 더 나아가 첨단 기기의 도입을 촉진할 것입니다.
예를 들어, 튜브리스 인슐린 펌프 기술 분야의 글로벌 리더인 인슐렛(Insulet Corporation)은 2023년 6월 20일, 옴니포드(Omnipod) 브랜드 제품으로 영국에서 2세 이상 1형 당뇨병 환자를 위한 옴니포드 5 자동 인슐린 투여 시스템(Omnipod 5)을 출시했습니다. 옴니포드 5 시스템은 간편함과 첨단 기술의 만남입니다. 옴니포드 5는 덱스콤 G6 연속 혈당 모니터링(CGM) 시스템과 통합되어 인슐린 투여량을 자동으로 조절하고 고혈당 및 저혈당으로부터 환자를 보호하는 최초의 CE 인증 튜브리스 하이브리드 폐쇄 루프 시스템입니다.
또한, 튜브리스 인슐린 펌프의 무선 연결 및 스마트 기능 통합은 사용자가 디지털 플랫폼을 통해 인슐린 투여량을 모니터링하고 제어할 수 있도록 지원합니다. 이러한 연결 수준은 환자의 편의성을 향상시킬 수 있습니다. 전반적으로 튜브리스 인슐린 펌프의 발전은 사용자 편의성을 개선하고 보급률을 더욱 높이고 있습니다.
예를 들어, 2023년 2월 14일 EOFlow Co.는 UAE에서 튜브리스, 착용형, 일회용 인슐린 펌프인 EOPatch를 출시했습니다. UAE에서는 새로운 Narsha 앱을 사용하여 Android 및 iOS 스마트폰에서 EOPatch를 통해 인슐린 주입을 직접 제어하고 관리할 수 있게 되었습니다.
또한 당뇨병 유병률 증가, FDA 승인과 같은 규제 기관 승인 증가, 튜브리스 인슐린 펌프의 장점에 대한 인식 제고, 기기 기술 발전 등이 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.
제약 요인
튜브리스 인슐린 펌프와 관련된 합병증 및 위험, 그리고 높은 가격은 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
글로벌 튜브리스 인슐린 펌프 시장은 유형, 구성 요소, 적용 분야, 유통 채널 및 지역별로 세분화됩니다.

패치형 인슐린 펌프 부문은 튜브리스 인슐린 펌프 시장 점유율의 약 43.2%를 차지했습니다.
패치형 인슐린 펌프 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 패치형 인슐린 펌프는 피부에 부착하는 웨어러블 인슐린 투여 장치로, 일반적으로 패치 형태입니다. 이 펌프는 인슐린을 지속적으로 투여하도록 설계되었습니다. 패치형 펌프는 눈에 띄지 않고 사용이 간편하며 일상생활에 지장을 주지 않는다는 장점을 제공합니다.
또한, 패치형 인슐린 펌프는 피부에 단단히 부착되도록 설계되어 사용자가 불편함 없이 장시간 착용할 수 있습니다. 예를 들어, 2022년 11월 16일, 영국 덱스콤은 네 명의 유명인이 직접 디자인한 연속혈당측정기(CGM) 패치형 인슐린 펌프를 통해 자신의 당뇨병 이야기를 전하는 캠페인을 시작했습니다.
당뇨병 유병률이 증가함에 따라 튜브리스 인슐린 펌프에 대한 수요도 지속적으로 증가하고 있습니다. 예를 들어, 미국 질병통제예방센터(CDC)에 따르면 2022년 기준 전 세계 당뇨병 환자는 총 3,730만 명입니다. 이러한 패치형 인슐린 펌프는 크기가 작고 눈에 잘 띄지 않아 사용자가 더욱 편리하게 사용할 수 있습니다.
지역 분석
북미 지역은 시장 점유율의 약 39.2%를 차지했습니다.
북미 지역은 주요 업체들의 강력한 입지와 지속적인 기술 발전으로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 특히 미국을 중심으로 의료기기 회사들을 비롯한 주요 업체들이 환자 편의성을 높이기 위해 더욱 발전된 기능을 제공하는 패치형 인슐린 펌프 개발에 주력하고 있습니다.

예를 들어, 2023년 4월 25일, 튜브리스 인슐린 펌프 기술 분야의 글로벌 리더인 인슐렛(Insulet Corporation)은 옴니포드(Omnipod) 브랜드 제품으로 최신 혁신 제품인 옴니포드 GO(Omnipod GO)의 FDA 승인을 발표했습니다. 옴니포드 GO는 18세 이상 제2형 당뇨병 환자 중 일반적으로 장시간 작용하는 인슐린을 매일 주사하는 환자에게 사용할 수 있도록 승인된 인슐린 전달 장치입니다. 튜브가 없고 방수 기능이 있는 포드를 특징으로 하는 옴니포드 GO는 기존의 인슐린 전달 방식에 대한 대안을 제공합니다.
또한, 이 지역에서 튜브리스 인슐린 펌프 기술의 발전이 가속화됨에 따라 시장 성장이 더욱 촉진될 것으로 예상됩니다. 예를 들어, 2022년 8월 11일, EOFlow는 당뇨병 관리 브랜드인 글루코멘 데이 펌프(GlucoMen Day PUMP)를 통해 튜브리스, 착용형, 일회용 인슐린 펌프를 공식 출시했습니다. 이러한 발전은 이 지역에서 튜브리스 인슐린 펌프의 보급을 확대할 것으로 기대됩니다.

경쟁 환경
전 세계 주요 튜브리스 인슐린 펌프 시장 업체로는 Insulet Corporation, F. Hoffmann-La Roche Ltd, Debiotech SA, CeQur Corporation, Terumo Corporation, Tandem Diabetes Care, Inc., EOFLOW CO., LTD., Medtrum Technologies Inc., Microtec Medical, Ascensia Diabetes Care Holdings AG 등이 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 튜브리스 인슐린 펌프 시장에 상당한 영향을 미쳤습니다. 팬데믹 기간 동안 튜브리스 인슐린 펌프에 대한 수요가 증가했습니다. 예를 들어, 미국 국립보건원(NIH)의 2020년 보고서에 따르면 비만과 당뇨병은 COVID-19로 인한 입원의 주요 위험 요인입니다. NIH는 당뇨병과 중증 비만 환자가 COVID-19에 감염될 가능성이 높고 사망 위험도 더 높다고 밝혔습니다. COVID-19로 인한 사망 위험이 높은 고령 환자 중 26.8%가 당뇨병을 앓고 있어 튜브리스 인슐린 펌프 도입에 대한 수요가 증가했습니다. 하지만 팬데믹은 이러한 기기의 전 세계적인 공급망에도 차질을 초래했습니다.
시장 세분화
유형별
• 인슐린 패치 펌프
• 일회용 저장소를 사용하는 기존 펌프
구성 요소별
• 인슐린 펌프(팟)
• 리모컨
적용 분야별
• 제1형 당뇨병
• 제2형 당뇨병
유통 채널별
• 병원 약국
• 소매 약국
• 온라인 약국
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
보고서 구매 이유

• 유형, 구성 요소, 적용 분야, 유통 채널 및 지역별 글로벌 튜브리스 인슐린 펌프 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.
• 모든 세그먼트를 포함한 튜브리스 인슐린 펌프 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 튜브리스 인슐린 펌프 시장 보고서는 약 69개의 표, 64개의 그림, 187페이지 분량입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global tubeless insulin pumps market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
Tubeless insulin pumps are basically worn as a patch directly on the body and controlled from a wireless handheld device, enabling discreet insulin delivery. The pump does not have a screen and is controlled wirelessly from a touchscreen handheld via Bluetooth. It includes an algorithm placed in a waterproof, closed-loop insulin pump and communicates directly with a continuous glucose monitor for the insulin-releasing process.
Moreover, tubeless insulin pumps can help people with type-1 and type-2 diabetes conveniently to manage their blood sugar levels. These small devices deliver doses of insulin at specific times. The tubeless insulin pumps are a more flexible option than insulin pen injections and other insulin devices. These don’t have to be permanent and can switch to another insulin management method at any time. Tubeless insulin pumps are favorable to the patients, insulin delivery can be done by using wireless devices.
Market Dynamics: Drivers
Increasing advancements in tubeless insulin pumps
The increasing advancements in tubeless pumps are expected to drive the market over the forecast period. The advancements in these pumps are expected to increase the adoption of tubeless insulin pumps. Advancements in tubeless insulin pump technology may result in devices that are smaller, more comfortable, and easier to use. Improvements in user experience can lead to increased patient satisfaction.
For instance, in August 2023, Roche launched its Accu-Chek Solo insulin patch pump and wireless touchscreen handheld device and it has received FDA approval for people with diabetes aged 2 years and older. The system includes a tubeless insulin pump and a wireless handheld controller with Bluetooth, which integrates with blood glucose monitoring and provides bolus advice. This insulin pump system is tubeless, small and lightweight. The device is detachable, allowing people with diabetes to change the infusion site when necessary.
Moreover, if tubeless insulin pumps are designed to integrate seamlessly with CGM systems, allowing for better glucose monitoring and automated insulin adjustments, it can significantly enhance diabetes management. This results in better patient outcomes and further this increases the adoption of advanced devices.
For instance, on June 20, 2023, Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products, launched its Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes in the United Kingdom. The Omnipod 5 System is where simplicity meets advanced technology. Omnipod 5 is the first CE-marked tubeless hybrid closed loop system that integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) System to automatically adjust insulin delivery and help protect against high and low glucose levels.
Furthermore, the incorporation of wireless connectivity and smart features of tubeless insulin pumps can empower users to monitor and control their insulin delivery through digital platforms. This level of connectivity can improve patient convenience. Overall, the advancements in tubeless insulin pumps improve user convenience and further increase adoption.
For instance, on February 14, 2023, EOFlow Co. launched its tubeless, wearable, and disposable insulin pump EOPatch in the UAE. It becomes possible in the UAE to control and manage insulin infusions with EOPatch directly from Android and iOS smartphones using the brand-new Narsha app.
In addition, the increasing prevalence of diabetes, rising regulatory approvals such as FDA approvals, increasing awareness about the advantages of tubeless insulin pumps and technological advancements in the devices are the factors expected to drive the market over the forecast period.
Restraints
Factors such as complications and risks associated with tubeless insulin pumps and the high cost of these devices are expected to hamper the market.
Segment Analysis
The global tubeless insulin pumps market is segmented based on type, component, application, distribution channel and region.
The insulin patch pumps segment accounted for approximately 43.2% of the tubeless insulin pumps market share
The insulin patch pumps segment is expected to hold the largest market share over the forecast period. Insulin patch pumps are a type of wearable insulin delivery device that adheres to the skin, typically in the form of a patch. These pumps are designed to provide a continuous delivery of insulin. They offer advantages such as discreetness, ease of use, and reduced interference with daily activities.
Moreover, insulin patch pumps are usually designed to adhere securely to the skin, allowing users to wear them for an extended period without discomfort. For instance, on November 16, 2022, Dexcom U.K. launched a campaign led by four local celebrities who designed their own continuous glucose monitor (CGM) insulin patch pumps to tell their Diabetes Story.
Due to the rising prevalence of diabetes, there is a continuously increasing demand for the use of tubeless insulin pumps. For instance, according to the Centers for Disease Control and Prevention, 2022, there are a total of 37.3 million people have diabetes. These insulin patch pumps are often compact and discreet, making them less noticeable and more convenient for users.
Geographical Analysis
North America accounted for approximately 39.2% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing advancements. North America especially the United States is home to the presence of major players such as medical device companies, which are primarily focussing on the development of tubeless insulin pumps by offering more advanced features to increase patient convenience.
For instance, on April 25, 2023, Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products, released the FDA clearance of its latest innovation, Omnipod GO, an insulin delivery device cleared for use for people with type 2 diabetes age 18 or older who would typically take daily injections of long-acting insulin. With its tubeless and waterproof pod, the Omnipod GO provides an alternative to traditional insulin delivery methods.
Furthermore, increasing advancements for tubeless insulin pumps in the region are also expected to drive the market in the region. For instance, on August 11, 2022, EOFlow officially launched its tubeless, wearable, and disposable insulin pump under the diabetes care brand GlucoMen Day PUMP. These advancements increase the adoption of tubeless insulin pumps in the region.
Competitive Landscape
The major global players in the tubeless insulin pumps market include Insulet Corporation, F. Hoffmann-La Roche Ltd, Debiotech SA, CeQur Corporation, Terumo Corporation, Tandem Diabetes Care, Inc., EOFLOW CO., LTD., Medtrum Technologies Inc., Microtec Medical and Ascensia Diabetes Care Holdings AG among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global tubeless insulin pumps market. During the pandemic, the demand for the tubeless insulin pumps has increased. For instance, according to NIH 2020, obesity and diabetes are two major risk factors for COVID‐19 hospitalization. The organization stated that people with diabetes mellitus and severe obesity are more likely to get infected and are at a higher risk of mortality from COVID-19. Among elderly patients who are at higher risk of death from COVID-19, 26.8% have diabetes mellitus, this increased the demand for the adoption of tubeless insulin pumps. However, the pandemic also disrupted the supply chain of these devices globally.
Market Segmentation
By Type
• Insulin Patch Pumps
• Traditional Pumps with Disposable Reservoirs
By Component
• Insulin Pump (Pod)
• Remote Controller
By Application
• Type-1 Diabetes
• Type-2 Diabetes
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?
• To visualize the global tubeless insulin pumps market segmentation based on type, component, application, distribution channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of tubeless insulin pumps market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global tubeless insulin pumps market report would provide approximately 69 tables, 64 figures, and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Component
3.3. Snippet by Application
3.4. Snippet by Distribution Channel
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Advancements in Tubeless Insulin Pumps
4.1.2. Restraints
4.1.2.1. High Cost of the Devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Insulin Patch Pumps*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Traditional Pumps with Disposable Reservoirs
8. By Component
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
8.1.2. Market Attractiveness Index, By Component
8.2. Insulin Pump (Pod)*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Remote Controller
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Type-1 Diabetes*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Type-2 Diabetes
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Hospital Pharmacies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Retail Pharmacies
10.4. Online Pharmacies
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Insulet Corporation*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. F. Hoffmann-La Roche Ltd
13.3. Debiotech SA
13.4. CeQur Corporation
13.5. Terumo Corporation
13.6. Tandem Diabetes Care, Inc.
13.7. EOFLOW CO., LTD.
13.8. Medtrum Technologies Inc.
13.9. Microtec Medical
13.10. Ascensia Diabetes Care Holdings AG
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Insulet Corporation, 4.	Key Developments, F. Hoffmann-La Roche Ltd, Debiotech SA, CeQur Corporation, Terumo Corporation, Tandem Diabetes Care, Inc., EOFLOW CO., LTD., Medtrum Technologies Inc., Microtec Medical, Ascensia Diabetes Care Holdings AG

표 목록 (Tables)

List of Tables

Table 1 Global Tubeless Insulin Pumps Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Tubeless Insulin Pumps Market Value, By Component, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Tubeless Insulin Pumps Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Tubeless Insulin Pumps Market Value, By Distribution Channel, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Tubeless Insulin Pumps Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Tubeless Insulin Pumps Market Value, By Type, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Tubeless Insulin Pumps Market Value, By Type, 2022-2031 (US$ Million)

Table 8 Global Tubeless Insulin Pumps Market Value, By Component, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Tubeless Insulin Pumps Market Value, By Component, 2022-2031 (US$ Million)

Table 10 Global Tubeless Insulin Pumps Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Tubeless Insulin Pumps Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Tubeless Insulin Pumps Market Value, By Distribution Channel, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Tubeless Insulin Pumps Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 14 Global Tubeless Insulin Pumps Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Tubeless Insulin Pumps Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Tubeless Insulin Pumps Market Value, By Type, 2022-2031 (US$ Million)

Table 17 North America Tubeless Insulin Pumps Market Value, By Component, 2022-2031 (US$ Million)

Table 18 North America Tubeless Insulin Pumps Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Tubeless Insulin Pumps Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 20 North America Tubeless Insulin Pumps Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Tubeless Insulin Pumps Market Value, By Type, 2022-2031 (US$ Million)

Table 22 South America Tubeless Insulin Pumps Market Value, By Component, 2022-2031 (US$ Million)

Table 23 South America Tubeless Insulin Pumps Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Tubeless Insulin Pumps Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 25 South America Tubeless Insulin Pumps Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Tubeless Insulin Pumps Market Value, By Type, 2022-2031 (US$ Million)

Table 27 Europe Tubeless Insulin Pumps Market Value, By Component, 2022-2031 (US$ Million)

Table 28 Europe Tubeless Insulin Pumps Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Tubeless Insulin Pumps Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 30 Europe Tubeless Insulin Pumps Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Tubeless Insulin Pumps Market Value, By Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Tubeless Insulin Pumps Market Value, By Component, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Tubeless Insulin Pumps Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Tubeless Insulin Pumps Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Tubeless Insulin Pumps Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa Tubeless Insulin Pumps Market Value, By Type, 2022-2031 (US$ Million)

Table 37 Middle East & Africa Tubeless Insulin Pumps Market Value, By Component, 2022-2031 (US$ Million)

Table 38 Middle East & Africa Tubeless Insulin Pumps Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa Tubeless Insulin Pumps Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 40 Insulet Corporation: Overview

Table 41 Insulet Corporation: Product Portfolio

Table 42 Insulet Corporation: Key Developments

Table 43 F. Hoffmann-La Roche Ltd: Overview

Table 44 F. Hoffmann-La Roche Ltd: Product Portfolio

Table 45 F. Hoffmann-La Roche Ltd: Key Developments

Table 46 Debiotech SA: Overview

Table 47 Debiotech SA: Product Portfolio

Table 48 Debiotech SA: Key Developments

Table 49 CeQur Corporation: Overview

Table 50 CeQur Corporation: Product Portfolio

Table 51 CeQur Corporation: Key Developments

Table 52 Terumo Corporation: Overview

Table 53 Terumo Corporation: Product Portfolio

Table 54 Terumo Corporation: Key Developments

Table 55 Tandem Diabetes Care, Inc.: Overview

Table 56 Tandem Diabetes Care, Inc.: Product Portfolio

Table 57 Tandem Diabetes Care, Inc.: Key Developments

Table 58 EOFLOW CO., LTD.: Overview

Table 59 EOFLOW CO., LTD.: Product Portfolio

Table 60 EOFLOW CO., LTD.: Key Developments

Table 61 Medtrum Technologies Inc.: Overview

Table 62 Medtrum Technologies Inc.: Product Portfolio

Table 63 Medtrum Technologies Inc.: Key Developments

Table 64 Microtec Medical: Overview

Table 65 Microtec Medical: Product Portfolio

Table 66 Microtec Medical: Key Developments

Table 67 Ascensia Diabetes Care Holdings AG: Overview

Table 68 Ascensia Diabetes Care Holdings AG: Product Portfolio

Table 69 Ascensia Diabetes Care Holdings AG: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 2 Global Tubeless Insulin Pumps Market Share, By Type, 2023 & 2031 (%)

Figure 3 Global Tubeless Insulin Pumps Market Share, By Component, 2023 & 2031 (%)

Figure 4 Global Tubeless Insulin Pumps Market Share, By Application, 2023 & 2031 (%)

Figure 5 Global Tubeless Insulin Pumps Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 6 Global Tubeless Insulin Pumps Market Share, By Region, 2023 & 2031 (%)

Figure 7 Global Tubeless Insulin Pumps Market Y-o-Y Growth, By Type, 2023-2031 (%)

Figure 8 Insulin Patch Pumps Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 9 Traditional Pumps with Disposable Reservoirs Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 10 Global Tubeless Insulin Pumps Market Y-o-Y Growth, By Component, 2023-2031 (%)

Figure 11 Insulin Pump (Pod) Component in Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 12 Remote Controller Component in Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 13 Global Tubeless Insulin Pumps Market Y-o-Y Growth, By Application, 2023-2031 (%)

Figure 14 Type-1 Diabetes Application in Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 15 Type-2 Diabetes Application in Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 16 Global Tubeless Insulin Pumps Market Y-o-Y Growth, By Distribution Channel, 2023-2031 (%)

Figure 17 Hospital Pharmacies Distribution Channel in Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 18 Retail Pharmacies Distribution Channel in Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 19 Online Pharmacies Distribution Channel in Global Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 20 Global Tubeless Insulin Pumps Market Y-o-Y Growth, By Region, 2023-2031 (%)

Figure 21 North America Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 22 Asia-Pacific Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 23 Europe Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 24 South America Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 25 Middle East and Africa Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 26 North America Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 27 North America Tubeless Insulin Pumps Market Share, By Type, 2023 & 2031 (%)

Figure 28 North America Tubeless Insulin Pumps Market Share, By Component, 2023 & 2031 (%)

Figure 29 North America Tubeless Insulin Pumps Market Share, By Application, 2023 & 2031 (%)

Figure 30 North America Tubeless Insulin Pumps Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 31 North America Tubeless Insulin Pumps Market Share, By Country, 2023 & 2031 (%)

Figure 32 South America Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 33 South America Tubeless Insulin Pumps Market Share, By Type, 2023 & 2031 (%)

Figure 34 South America Tubeless Insulin Pumps Market Share, By Component, 2023 & 2031 (%)

Figure 35 South America Tubeless Insulin Pumps Market Share, By Application, 2023 & 2031 (%)

Figure 36 South America Tubeless Insulin Pumps Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 37 South America Tubeless Insulin Pumps Market Share, By Country, 2023 & 2031 (%)

Figure 38 Europe Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 39 Europe Tubeless Insulin Pumps Market Share, By Type, 2023 & 2031 (%)

Figure 40 Europe Tubeless Insulin Pumps Market Share, By Component, 2023 & 2031 (%)

Figure 41 Europe Tubeless Insulin Pumps Market Share, By Application, 2023 & 2031 (%)

Figure 42 Europe Tubeless Insulin Pumps Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 43 Europe Tubeless Insulin Pumps Market Share, By Country, 2023 & 2031 (%)

Figure 44 Asia-Pacific Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 45 Asia-Pacific Tubeless Insulin Pumps Market Share, By Type, 2023 & 2031 (%)

Figure 46 Asia-Pacific Tubeless Insulin Pumps Market Share, By Component, 2023 & 2031 (%)

Figure 47 Asia-Pacific Tubeless Insulin Pumps Market Share, By Application, 2023 & 2031 (%)

Figure 48 Asia-Pacific Tubeless Insulin Pumps Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 49 Asia-Pacific Tubeless Insulin Pumps Market Share, By Country, 2023 & 2031 (%)

Figure 50 Middle East & Africa Tubeless Insulin Pumps Market Value, 2022-2031 (US$ Million)

Figure 51 Middle East & Africa Tubeless Insulin Pumps Market Share, By Type, 2023 & 2031 (%)

Figure 52 Middle East & Africa Tubeless Insulin Pumps Market Share, By Component, 2023 & 2031 (%)

Figure 53 Middle East & Africa Tubeless Insulin Pumps Market Share, By Application, 2023 & 2031 (%)

Figure 54 Middle East & Africa Tubeless Insulin Pumps Market Share, By Distribution Channel, 2023 & 2031 (%)

Figure 55 Insulet Corporation: Financials

Figure 56 F. Hoffmann-La Roche Ltd: Financials

Figure 57 Debiotech SA: Financials

Figure 58 CeQur Corporation: Financials

Figure 59 Terumo Corporation: Financials

Figure 60 Tandem Diabetes Care, Inc.: Financials

Figure 61 EOFLOW CO., LTD.: Financials

Figure 62 Medtrum Technologies Inc.: Financials

Figure 63 Microtec Medical: Financials

Figure 64 Ascensia Diabetes Care Holdings AG: Financials

글로벌 튜브리스 인슐린 펌프 시장 – 2023-2030

Global Tubeless Insulin Pumps Market - 2023-2030